Preview

Tuberculosis and Lung Diseases

Advanced search
Fullscreen

For citations:


Kukurika A.V. DprE1 inhibitors – a prospective target for development of antituberculosis drugs. Tuberculosis and Lung Diseases. 2022;100(5):64-70. (In Russ.) https://doi.org/10.21292/2075-1230-2022-100-5-64-70

Views PDF (Rus): 439


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2075-1230 (Print)
ISSN 2542-1506 (Online)